These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 3829985)

  • 1. Gentamicin-induced alterations of intralysosomal pH and lysosomal enzyme activities.
    Oshima M; Hashiguchi M; Shindo N; Shibata S
    Dev Toxicol Environ Sci; 1986; 14():91-100. PubMed ID: 3829985
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical mechanisms of aminoglycoside cell toxicity. I. The uptake of gentamicin by cultured skin fibroblasts and the alteration of lysosomal enzyme activities.
    Oshima M; Hashiguchi M; Shindo N; Shibata S
    J Biochem; 1986 Dec; 100(6):1575-82. PubMed ID: 3571189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against gentamicin-induced early renal alterations (phospholipidosis and increased DNA synthesis) by coadministration of poly-L-aspartic acid.
    Beauchamp D; Laurent G; Maldague P; Abid S; Kishore BK; Tulkens PM
    J Pharmacol Exp Ther; 1990 Nov; 255(2):858-66. PubMed ID: 2243354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gentamicin-induced lysosomal phospholipidosis in cultured rat fibroblasts. Quantitative ultrastructural and biochemical study.
    Aubert-Tulkens G; Van Hoof F; Tulkens P
    Lab Invest; 1979 Apr; 40(4):481-91. PubMed ID: 431047
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of gentamicin on the lysosomal system of cultured human proximal tubular cells. Endocytotic activity, lysosomal pH and membrane fragility.
    Regec AL; Trump BF; Trifillis AL
    Biochem Pharmacol; 1989 Aug; 38(15):2527-34. PubMed ID: 2474296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative toxicity of aminoglycoside antibiotics towards the lysosomes in a cell culture model.
    Tulkens P; Van Hoof F
    Toxicology; 1980; 17(2):195-9. PubMed ID: 7210003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. II. Comparative in vitro and in vivo studies with poly-L-aspartic, poly-L-glutamic and poly-D-glutamic acids.
    Kishore BK; Lambricht P; Laurent G; Maldague P; Wagner R; Tulkens PM
    J Pharmacol Exp Ther; 1990 Nov; 255(2):875-85. PubMed ID: 1700819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. I. Polyaspartic acid binds gentamicin and displaces it from negatively charged phospholipid layers in vitro.
    Kishore BK; Kállay Z; Lambricht P; Laurent G; Tulkens PM
    J Pharmacol Exp Ther; 1990 Nov; 255(2):867-74. PubMed ID: 2243355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gentamicin-induced renal metabolic alterations in newborn rat kidney: lack of potentiation by vancomycin.
    Kacew S; Hewitt WR; Hook JB
    Toxicol Appl Pharmacol; 1989 Jun; 99(1):61-71. PubMed ID: 2524910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gentamicin induces a lysosomal phospholipidosis in cultured rat fibroblast [proceedings].
    Goffeau A; Aubert-Tulkens G; Van Hoff F
    Arch Int Physiol Biochim; 1978 May; 86(2):403-5. PubMed ID: 80995
    [No Abstract]   [Full Text] [Related]  

  • 11. Leupeptin and E-64, inhibitors of cysteine proteinases, prevent gentamicin-induced lysosomal phospholipidosis in cultured rat fibroblasts.
    Montenez JP; Kishore BK; Maldague P; Tulkens PM
    Toxicol Lett; 1994 Sep; 73(3):201-8. PubMed ID: 8091428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gentamicin-induced apoptosis in LLC-PK1 cells: involvement of lysosomes and mitochondria.
    Servais H; Van Der Smissen P; Thirion G; Van der Essen G; Van Bambeke F; Tulkens PM; Mingeot-Leclercq MP
    Toxicol Appl Pharmacol; 2005 Aug; 206(3):321-33. PubMed ID: 16039943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tricyclic antidepressant desipramine causes proteolytic degradation of lysosomal sphingomyelinase in human fibroblasts.
    Hurwitz R; Ferlinz K; Sandhoff K
    Biol Chem Hoppe Seyler; 1994 Jul; 375(7):447-50. PubMed ID: 7945993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular toxicity of gentamicin.
    Libert J; Ketelbant-Balasse PE; Van Hoof F; Aubert-Tulkens G; Tulkens P
    Am J Ophthalmol; 1979 Mar; 87(3):405-11. PubMed ID: 219698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid and lysosomal enzymes in human fibroblasts cultured with perhexiline maleate.
    Albouz S; Boutry JM; Dubois G; Bourdon R; Hauw JJ; Baumann N
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Sep; 317(2):173-7. PubMed ID: 7300921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gentamicin-induced nephrotoxicity: a cell biology approach.
    Morin JP; Viotte G; Vandewalle A; Van Hoof F; Tulkens P; Fillastre JP
    Kidney Int; 1980 Nov; 18(5):583-90. PubMed ID: 6109786
    [No Abstract]   [Full Text] [Related]  

  • 17. Phospholipids and acidic sphingomyelinase in human meningiomas.
    Kostić D; Vranesević A; Nagulić I
    Neurologija; 1982; 30(1-4):3-10. PubMed ID: 6320026
    [No Abstract]   [Full Text] [Related]  

  • 18. Co-oxydextran as a protectant against gentamicin-induced renal lysosomal phospholipidosis and focal tubular necrosis. Perspectives and limitations.
    Kishore BK; Van Schepdael A; Laurent G; Lambricht P; Claes PJ; Piret J; Tulkens PM; Maldague P
    Contrib Nephrol; 1993; 101():213-9. PubMed ID: 7682169
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of glycyrrhizin on lysosomes labilization by phospholipase A2.
    Shiki Y; Ishikawa Y; Shirai K; Saito Y; Yoshida S
    Am J Chin Med; 1986; 14(3-4):131-7. PubMed ID: 3799529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperactivity of cathepsin B and other lysosomal enzymes in fibroblasts exposed to azithromycin, a dicationic macrolide antibiotic with exceptional tissue accumulation.
    Gerbaux C; Van Bambeke F; Montenez JP; Piret J; Morlighem G; Tulkens PM
    FEBS Lett; 1996 Oct; 394(3):307-10. PubMed ID: 8830663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.